Readoutin 45d
Vertex Pharmaceuticals Incorporated — Suzetrigine
Phase 3 primary completion: Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN).
- Date
- Jan 2027
- Type
- Readout
- Indication
- Diabetic Peripheral Neuropathic Pain